Cagrilinitide

Jump to section
Uses Dosing Protocol Reconst Inject Supplies Source Works Effects

Cagrilintide

Cagrilintide is a long-acting amylin analogue currently being researched for its interaction with appetite regulation, gastric emptying, and metabolic signaling pathways. Research has focused on its potential role in influencing satiety-related mechanisms and supporting reduced caloric intake through central and peripheral signaling activity.

Studies have explored how Cagrilintide may work alongside GLP-1 pathway activity to support metabolic regulation and body composition research.

Metabolic Fat Loss Appetite

Common Research Uses

  • Metabolic signaling pathway
  • Appetite regulation and satiety
  • Body composition and weight management
  • Gastric emptying and digestive response analysis

Typical Research Dosing

Weekly Range: 0.6–4.5 mg
Frequency: Once weekly
Common Cycle Length: 8–16 weeks
🧮 Calculate dose → 💧 Reconstitution steps 📥 View QuickStart card

Subcutaneous Protocol (10 mg + 3 mL BAC = ~3.33 mg/mL)

Phase Weekly Dose (mg) Units per Injection
Weeks 1-2 0.6 mg once weekly 18 units
Weeks 3-4 1.2 mg once weekly 36 units
Weeks 5-6 2.4 mg once weekly 72 units
Weeks 7-16 (Maintenance) 4.5 mg once weekly 135 units

Based on reconstitution of 10 mg with 3 mL bacteriostatic water (~3.33 mg/mL).

Reconstitution Steps

Your Mix: 10 mg peptide + 3 mL bacteriostatic water = ~3.33 mg/mL
  1. Prep clean: Wash hands, use a clean surface, and gather supplies.
  2. Sanitize: Alcohol swab vial stoppers and allow to air-dry.
  3. Add diluent slowly: Inject bacteriostatic water down the vial wall to reduce foaming.
  4. Mix gently: Gently swirl or roll until fully dissolved. Do not shake.
  5. Label: Write compound name, date, and concentration (mg/mL).
  6. Store appropriately: Store according to supplier guidance and maintain sterile technique.

Educational reference only

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

  • Allow the peptide to reach room temperature before injection.
  • Clean the vial stopper and injection site with alcohol and allow to fully dry.
  • Pinch a small skinfold and insert the needle at a 45–90° angle into subcutaneous tissue.
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate injection sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
  • Inject slowly to help minimize any stinging sensation.

This information is provided for educational reference only and reflects general clinical best practices.

How It Works

Cagrilintide is a synthetic analogue of amylin, a naturally occurring hormone co-secreted with insulin by pancreatic beta cells. Amylin plays a role in regulating appetite, food intake, and gastric emptying through signaling pathways in both the digestive system and central nervous system.

Research suggests Cagrilintide works by activating amylin receptors involved in satiety signaling. This activity may help slow gastric emptying, reduce hunger signaling, and promote feelings of fullness following food intake. Studies have also explored its effects on reward-related eating behaviors and overall caloric consumption patterns.

At the cellular and systemic level, Cagrilintide has been studied for its interaction with metabolic regulation pathways associated with energy balance and nutrient intake. Researchers have shown interest in its potential synergistic relationship with GLP-1 receptor agonists due to complementary appetite-regulating mechanisms. Unlike traditional stimulant-based weight management compounds, Cagrilintide is being researched for its hormone-mimicking mechanism focused on satiety and metabolic signaling pathways rather than central nervous system stimulation.

Commonly Reported Side Effects

  • Fatigue
  • Reduced Appetite
  • Fullness Sensations
  • Nausea
  • Injection site reactions

These effects are based on commonly reported research observations and may vary by individual.

↑